Reserch Development
Quality policy
Drug Safety
Cutaden® Bebe
1. Reference documents
2. Corporate Governance Regulation

Export Brochure 

Quality, safety, health and environmental  policy

Annual Report 2014



December 11th - Romanian continuity and performance!
Nowadays, Antibiotice is one of the key drug manufacturers in Romania. Every year new drugs from various therapeutic classes were added to its portfolio so that a balanced product classification was created containing both traditional drugs as well as new generation drugs. 

The Antibiotice Company achieved its forecasted profit target for the first half of 2015
The revenues from sales of the Antibiotice Company during the first half of the year 2015 amounted to 132.39 million lei, up by 1% compared to the amount planned in the Revenues and Expenditure Budget. The gross profit recorded during the first 6 months of the year amounted to 16.6 million lei, an amount budgeted at the beginning of the year and the net profit recorded the level of 15.3 million lei.

Antibiotice 60 years
From an API manufacturer to pharmaceutical domestic market leader

Copyright 2009 Antibiotice SA Toate drepturile rezervate